COEP

NASDAQStock

Coeptis Therapeutics, Inc.

$12.01-0.06 (-0.50%)

52-Week Range

$7.05

$18.80

Key Stats

Market Cap

—

P/E Ratio

—

Dividend Yield

—

Beta

-0.47

Volume

65.8K

Avg Volume

44.7K

Performance

-0.33%

-20.01%

-3.44%

YTD

-17.55%

+42.00%

-52.48%

-90.72%

Price Chart

ETF Exposure

COEP is held by 7 ETFs

ETF	Fund Name	Weight	Shares	Market Value	Fund AUM	Expense Ratio
VXF	Vanguard Extended Market ETF	0.00%	42,366	$587K	$84.10B	0.05%
VCNS.TO	Vanguard Conservative ETF Portfolio	0.00%	12	$237	$820.6M	0.25%
VEQT.TO	Vanguard All-Equity ETF Portfolio	0.00%	450	$8K	$12.17B	0.24%
VRIF.TO	Vanguard Retirement Income ETF Portfolio	0.00%	2	$40	$337.7M	0.32%
VTI	Vanguard Total Stock Market ETF	0.00%	256,549	$3.6M	$2.10T	0.03%
VUN.TO	Vanguard U.S. Total Market Index ETF	0.00%	1,349	$25K	$15.33B	0.17%
VUS.TO	Vanguard U.S. Total Market Index ETF (CAD-hedged)	0.00%	116	$2K	$1.29B	0.17%

About COEP ETF Exposure

Coeptis Therapeutics, Inc. (COEP) is held by 7 exchange-traded funds, making it one of the stocks with significant ETF exposure. The stock currently trades at $12.01. Investors can gain exposure to COEP through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold COEP, sorted by portfolio weight.